Screening Preeclampsia Genes and the Effects of CITED2 on Trophoblastic Function
Authors:
Open Access
- 1 August 2024
- journal article
- research article
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 17, 3493-3509
Abstract
Purpose: Preeclampsia (PE) is a serious complication of obstetrics and represents a significant challenge in terms of understanding its underlying mechanism. It has been shown that a number of disorders involve dysregulation of the CBP/p300-interacting transactivator with glutamic acid/aspartic acid-rich carboxyl-terminal domain 2 (CITED2). However, the relationship between PE and CITED2 is still mostly unclear. This work aimed to confirm the hub genes linked to PE and explore the roles of CITED2 in trophoblast using experimental and bioinformatic methods. Methods: To determine the hub genes, bioinformatics research was performed on two datasets from the Gene Expression Omnibus (GEO) public database. Immune infiltration analysis and enrichment analysis were also used to identify the related pathways and immune cells. PCR and WB were then used to validate the mRNA and protein levels of CITED2 in the PE samples. Finally, the expression of CITED2 was knocked down using siRNA to investigate the function of CITED2 in trophoblast development in vitro. Results: The study’s findings showed that the NOTCH signaling pathways, glycolysis, and hypoxia were the main areas of enrichment for the six PE-related genes that were tested. The results of immune infiltration suggest that activated NK cells and regulatory T cells may play an important role in this process. CITED2 was significantly upregulated in the PE placenta. In functional tests, the knockdown of CITED2 may enhance apoptosis while suppressing migration, invasion, and proliferation of cells. Conclusion: This study offers important proof that CITED2 influences trophoblast cell function and may one day be a therapeutic target for PE.Keywords
This publication has 50 references indexed in Scilit:
- The prediction of preeclampsia: the way forwardAmerican Journal of Obstetrics and Gynecology, 2022
- Dysregulated GLUT1 may be involved in the pathogenesis of preeclampsia by impairing decidualizationMolecular and Cellular Endocrinology, 2022
- Clinical tools and biomarkers to predict preeclampsiaEBioMedicine, 2021
- Cellular immune responses in the pathophysiology of preeclampsiaJournal of Leukocyte Biology, 2021
- MicroRNA‐16 is involved in the pathogenesis of pre‐eclampsia via regulation of Notch2Journal of Cellular Physiology, 2019
- The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre‐eclampsia: A pragmatic guide for first‐trimester screening and preventionInternational Journal of Gynecology & Obstetrics, 2019
- Acute Loss of Cited2 Impairs Nanog Expression and Decreases Self-Renewal of Mouse Embryonic Stem CellsStem Cells, 2014
- Decidual Cell Regulation of Natural Killer Cell–Recruiting ChemokinesThe American Journal of Pathology, 2013
- CITED2 modulates estrogen receptor transcriptional activity in breast cancer cellsBiochemical and Biophysical Research Communications, 2013
- Differential Regulation of Human PlGF Gene Expression in Trophoblast and Nontrophoblast Cells by Oxygen TensionPlacenta, 2009